From research to reality: progress in Motor Neuron Disease treatments at UCL

This Brain Awareness Week, we’re shining a light on how UCL is transforming our understanding of the brain.

Motor Neuron Disease (MND) is a serious and uncurable condition. Researchers at UCL are working on new treatments thanks to a £78 million investment.

In the video below, Prof. Pietro Fratta, Prof. Elizabeth Fisher (UCL Queen Square Institute of Neurology) and Dr Oscar Wilkins (Francis Crick Institute) talk about the pace of the research’s progress.

The UCL Translational Research Office (TRO) is pleased to have supported Prof. Fratta and his team in securing funding and establishing key collaborations for their work on targeting UNC13A, a protein essential for MND patients. This research has also led to the creation of the spin-out company Trace Neuroscience supported by UCL Business Ltd.

Together we are committed to supporting UCL researchers in translating discoveries into impact.

Find out more about the new treatment here.

Discover how UCL academics are driving groundbreaking discoveries and innovations.

YouTube Widget Placeholderhttps://youtu.be/Rvby5nw-BRM?si=-g-YA4bLerIF2fc_

Credit: UCL Faculty of Brain Sciences

Interested to stay informed of upcoming news, events and funding calls?

• Subscribe to our newsletter and you would automatically become a member of UCL TINs (Therapeutic Innovation Networks) and be the first to receive our event invitations

• Follow us on social media (LinkedIn, Bluesky, X) and stay tuned to our news and updates.